PHASE-II TRIAL OF CISPLATIN IN ADVANCED OR RECURRENT CANCER OF THE VAGINA - A GYNECOLOGIC ONCOLOGY GROUP-STUDY

被引：19
|
作者：
THIGPEN, JT
BLESSING, JA
HOMESLEY, HD
BEREK, JS
CREASMAN, WT
机构：
[1] UNIV MISSISSIPPI,MED CTR,SCH MED,DEPT MED & OBSTET & GYNECOL,JACKSON,MS 39216
[2] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,CANC RES SCI 5,GYNECOL ONCOL GRP,BUFFALO,NY 14263
[3] WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT OBSTET & GYNECOL,GYNECOL ONCOL SECT,WINSTON SALEM,NC 27103
[4] UNIV CALIF LOS ANGELES,SCH MED,DIV GYNECOL ONCOL,LOS ANGELES,CA 90024
[5] DUKE UNIV,MED CTR,DEPT OBSTET & GYNECOL,DURHAM,NC 27710
来源：
GYNECOLOGIC ONCOLOGY | 1986年 / 23卷 / 01期
关键词：
D O I：
10.1016/0090-8258(86)90121-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：101 / 104
页数：4
相关论文
共 50 条
  • [21] PHASE-II CLINICAL-STUDY OF TAMOXIFEN IN ADVANCED ENDOMETRIAL ADENOCARCINOMA - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    SLAVIK, M
    PETTY, WM
    BLESSING, JA
    CREASMAN, WT
    HOMESLEY, HD
    CANCER TREATMENT REPORTS, 1984, 68 (05): : 809 - 811
  • [22] A PHASE-II TRIAL OF DIDEMNIN-B (NSC NO.325319) IN ADVANCED AND RECURRENT CERVICAL-CARCINOMA - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    JACOBS, AJ
    BLESSING, JA
    MUNOZ, A
    GYNECOLOGIC ONCOLOGY, 1992, 44 (03) : 268 - 270
  • [23] PHASE-II TRIAL OF BISANTRENE IN PATIENTS WITH ADVANCED SARCOMA - A SOUTHWEST ONCOLOGY GROUP-STUDY
    COWAN, JD
    GEHAN, E
    RIVKIN, SE
    JONES, SE
    CANCER TREATMENT REPORTS, 1986, 70 (05): : 685 - 686
  • [24] PHASE-II TRIAL OF IFOSFAMIDE AND CISPLATIN IN THE TREATMENT OF METASTATIC SARCOMAS - A SOUTHWEST ONCOLOGY GROUP-STUDY
    BUDD, GT
    METCH, B
    WEISS, SAW
    WEICK, JK
    FABIAN, C
    STEPHENS, RL
    BALCERZAK, SP
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1993, 31 : S213 - S216
  • [25] PHASE-II TRIAL OF PIPERAZINEDIONE IN THE TREATMENT OF ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    THIGPEN, JT
    BLESSING, JA
    HOMESLEY, HD
    PETTY, W
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1986, 9 (01): : 21 - 23
  • [26] PHASE-II TRIAL OF ETOPOSIDE IN THE MANAGEMENT OF ADVANCED AND RECURRENT LEIOMYOSARCOMA OF THE UTERUS - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    SLAYTON, RE
    BLESSING, JA
    ANGEL, C
    BERMAN, M
    CANCER TREATMENT REPORTS, 1987, 71 (12): : 1303 - 1304
  • [27] PHASE-II TRIAL OF ETOPOSIDE IN THE MANAGEMENT OF ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    SLAYTON, RE
    BLESSING, JA
    DELGADO, G
    CANCER TREATMENT REPORTS, 1982, 66 (08): : 1669 - 1671
  • [28] PHASE-II TRIAL OF PIPERAZINEDIONE IN PATIENTS WITH ADVANCED OR RECURRENT UTERINE SARCOMA - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    THIGPEN, JT
    BLESSING, JA
    HOMESLEY, HD
    HACKER, N
    CURRY, SL
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1985, 8 (05): : 350 - 352
  • [29] A PHASE-II TRIAL OF GALLIUM NITRATE (NSC-15200) IN ADVANCED OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    MALFETANO, JH
    BLESSING, JA
    HOMESLEY, HD
    HANJANI, P
    INVESTIGATIONAL NEW DRUGS, 1991, 9 (01) : 109 - 111
  • [30] A PHASE-II TRIAL OF DIAZIQUONE (AZQ) IN MIXED MESODERMAL SARCOMAS OF THE UTERUS - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    SLAYTON, RE
    BLESSING, JA
    CLARKEPEARSON, D
    INVESTIGATIONAL NEW DRUGS, 1991, 9 (01) : 93 - 94
12345